6
Participants
Start Date
July 10, 2017
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Oxandrin
"The primary outcome for this study will be measurements of the pharmacokinetics of a single dose of oxandrolone 0.1 mg/kg both in tablet form and in the MCT oil preparation. Blood samples for pharmacokinetics will be drawn at 9 timepoints.~Safety will be assessed by recording adverse events and assessment of hepatic function at baseline and one week following oxandrolone dosing."
Primary Children's Hospital, Salt Lake City
University of Utah
OTHER